Dermatophytic Onychomycosis Treatment Market Size to Surpass USD 8.64 Billion by 2030, exhibiting a CAGR of 8.0%

As per the report by Fortune Business Insights, the global Dermatophytic Onychomycosis Treatment Market size is projected to reach USD 8.64 billion in 2030, at a CAGR of 8.0% during the forecast period, 2023-2030

Dermatophytic Onychomycosis Treatment Market

Pune, India, Sept. 27, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, the global Dermatophytic Onychomycosis Treatment Market Size was valued at USD 4.68 billion in 2022 and is projected to grow from USD 5.05 billion in 2023 to USD 8.64 billion by 2030, exhibiting a CAGR of 8.0% during the forecast period. The expansion can be credited to the growing geriatric population. Various research studies cite that the prevalence of this condition increases with age. This information is provided by Fortune Business Insights™ in its research report titled Dermatophytic Onychomycosis Treatment Market, 2023-2030.

Key Industry Development-

March 2021: HUYABIO International in collaboration with Tianjin Institute of Pharmaceutical Research submitted a Chinese New Drug Application for Efinaconazole as Jublia for treating onychomycosis.

Request a Sample PDF – https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermatophytic-onychomycosis-treatment-market-103310

Key Takeaways –

• Dermatophytic Onychomycosis Treatment Market size in North America was USD 2.07 billion in 2022
• Increasing Incidence of Dermatophytic Onychomycosis Expected to Propel Market Expansion
• The Existence of Promising Pipeline Candidates to Stimulate Market Expansion
• The nail paints segment is expected to hold a major market share during the projected period.

Discover the Leading Players Featured in the Report-

• Bausch Health Companies Inc. (Canada)
• Pfizer Inc. (U.S.)
• Galderma (Switzerland)
• GlaxoSmithKline plc (U.K.)
• Janssen Pharmaceuticals, Inc. (U.S.)
• Cipla Inc. (India)
• Kaken Pharmaceuticals Co., Ltd. (Japan)

Report Scope & Segmentation:

Browse Complete Report Details- https://www.fortunebusinessinsights.com/dermatophytic-onychomycosis-treatment-market-103310

Drivers & Restraints:

Rising Prevalence of Dermatophytic Onychomycosis to Drive the Market Growth

One of the major factors driving the dermatophytic onychomycosis treatment market growth is the growing occurrence of onychomycosis. When compared to that of fingernails, the toenail onychomycosis infection is more common.

Despite such growth opportunities, the unawareness among patients about the seriousness of the infection may hinder the market growth.

Segmentation:

By Product Type

• Tablets
• Nail Paints

By Route of Administration

• Oral
• Topical

By Type

• Prescribed
• Over-the-Counter (OTC)

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Channels

Regional Insights:

North America to Dominate Owing to Growing Number of Prescriptions for Onychomycosis

The North America dermatophytic onychomycosis treatment market share is projected to witness significant growth over the forecast period. The regional expansion can be credited to the surging number of prescriptions for onychomycosis. As per Moberg Pharma AB’s press release, around 5 million prescriptions are written for onychomycosis treatment every year in the region.

The Asia Pacific market for dermatophytic onychomycosis treatment is expected to expand significantly during the forecast period. The growing prevalence of diabetes has increased the need for dermatophytic onychomycosis treatment in the region, fueling market expansion.

Quick Buy – Dermatophytic Onychomycosis Treatment Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/103310

Competitive Landscape:

Prominent Companies Invest in Product Innovations to Outperform the Competitors

Top players of dermatophytic onychomycosis treatment are investing substantial amounts in R&D for the development of innovative products. Some other competitive strategies deployed by companies include mergers and acquisitions, joint ventures, partnerships, and others.

FAQs

How big is the Dermatophytic Onychomycosis Treatment Market?

Dermatophytic Onychomycosis Treatment Market size was USD 4.68 billion in 2022. It is expected to reach USD 8.64 billion in 2030.

How fast is the Dermatophytic Onychomycosis Treatment Market growing?

The Dermatophytic Onychomycosis Treatment Market will exhibit a CAGR of 8.0% during the forecast period, 2023-2030.

Related Reports:

Dermatology Drugs Market Size, Share, Revenue Forecast and Opportunities

Global Anti Fungal Drugs Market Overview, Industry Share and Forecast

Skincare Market Trends, Growth and Global Forecast Report

Medical Aesthetics Market Size, Share, Opportunities & Analysis

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Attachment

• Dermatophytic Onychomycosis Treatment Market

otc
tsx-bhc
bausch-health-companies-inc
bausch health companies inc
press-release